Parschauer Karah Herdman insider trades
Parschauer Karah Herdman has filed 30 Form 4s with the SEC that we hold, for Ultragenyx Pharmaceutical Inc. (RARE) (EVP and Chief Legal Officer), Evolus, Inc. (EOLS) (Director), Tenaya Therapeutics, Inc. (TNYA) (Director) and Anebulo Pharmaceuticals, Inc. (ANEB) (Director). Across all of them we count 0 purchases worth $0 and 19 sales worth $3.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 5 sales ($487.9K). The largest single trade was a sale of 7,336 shares of Ultragenyx Pharmaceutical Inc. worth $738.4K, dated 2021-09-08. The first filing on our record is dated 2021-09-09 and the latest 2026-08-04.
Ultragenyx Pharmaceutical Inc. (RARE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-08 | S, sale reported on Form 4 | 7,336 | $738.4K | 2021-09-09 |
| 2021-10-14 | S, sale reported on Form 4 | 310 | $25.2K | 2021-10-18 |
| 2022-03-01 | S, sale reported on Form 4 | 2,886 | $192.3K | 2022-03-03 |
| 2022-03-07 | S, sale reported on Form 4 | 5,140 | $323.6K | 2022-03-08 |
| 2023-03-01 | S, sale reported on Form 4 | 3,161 | $143.0K | 2023-03-03 |
| 2023-05-04 | S, sale reported on Form 4 | 4,378 | $197.0K | 2023-05-05 |
| 2024-03-01 | S, sale reported on Form 4 | 3,756 | $201.9K | 2024-03-05 |
| 2024-06-12 | S, sale reported on Form 4 | 9,806 | $441.3K | 2024-06-12 |
| 2025-02-27 | S, sale reported on Form 4 | 2,230 | $95.7K | 2025-03-03 |
| 2025-02-27 | S, sale reported on Form 4 | 760 | $32.5K | 2025-03-03 |
| 2025-03-03 | S, sale reported on Form 4 | 12,846 | $540.8K | 2025-03-04 |
| 2025-09-12 | S, sale reported on Form 4 | 2,450 | $76.4K | 2025-09-12 |
| 2026-03-02 | S, sale reported on Form 4 | 8,135 | $185.5K | 2026-03-03 |
| 2026-03-06 | S, sale reported on Form 4 | 6,018 | $128.8K | 2026-03-10 |
| 2026-03-10 | S, sale reported on Form 4 | 3,508 | $79.5K | 2026-03-10 |
| 2026-06-15 | S, sale reported on Form 4 | 1,899 | $46.8K | 2026-06-15 |
| 2026-08-03 | S, sale reported on Form 4 | 1,900 | $47.3K | 2026-08-04 |
Evolus, Inc. (EOLS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-01-30 | S, sale reported on Form 4 | 11,931 | $156.8K | 2024-02-02 |
| 2025-03-12 | S, sale reported on Form 4 | 12,888 | $167.4K | 2025-03-14 |
Tenaya Therapeutics, Inc. (TNYA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Anebulo Pharmaceuticals, Inc. (ANEB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1677455) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms